Literature DB >> 28903883

The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.

Wen-Chen Liang1, Chen-Hua Wang2, Po-Ching Chou2, Wan-Zi Chen3, Yuh-Jyh Jong4.   

Abstract

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common hereditary muscular dystrophy and caused by DMD gene mutation. In addition to progressive proximal muscle weakness, respiratory, orthopedic, and gastrointestinal complications are often observed in DMD. The natural history of patients with DMD in Taiwan has not been reported thus far.
METHODS: Medical records of 39 patients who received a diagnosis of DMD between 1999 and 2016 at Kaohsiung Medical University Hospital were reviewed. The diagnosis of DMD was confirmed through muscle biopsy or DMD genetic analysis.
RESULTS: The mean onset age and mean follow-up period were 2.75 years and 6.76 years, respectively. Seventeen patients (43.5%) had a family history of DMD. The mean full intelligence quotient of the patients was 71.08, and the mean age of walking ability loss was 9.7 years (25 patients). The mean onset age of respiratory insufficiency was 10.64 years with a decline rate of 5.18% per year (25 patients). The mean onset age of cardiomyopathy was 14.69 years (seven patients). The mean onset age of scoliosis was 13.29 years with a progression rate of 11.48° per year (14 patients). Eleven (28.2%) and eight (20.5%) patients had deletions and duplications of DMD, respectively. Fourteen patients (35.9%) had point mutations or small deletions or insertions. Five patients received only multiplex ligation-dependent probe amplification (MLPA) analysis and exhibited neither deletion nor duplication. No mutation was identified in one patient through both MLPA and exon sequencing.
CONCLUSION: The clinical phenotypes and disease course in our cohort were consistent with that reported in previous studies. However, the proportion of point mutations or small deletions or insertions in our study was considerably higher than that in reports from other populations. Cardiac ejection fraction was found not a reliable biomarker for identifying cardiac problems, discovering a better parameter is necessary.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Duchenne muscular dystrophy; Taiwan; corticosteroid; natural history

Mesh:

Substances:

Year:  2017        PMID: 28903883     DOI: 10.1016/j.pedneo.2017.02.004

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  3 in total

1.  Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Wen-Chin Weng; Li-Chu Chen; Yu-Hsuan Huang; Chao-Szu Wu; Wuh-Liang Hwu
Journal:  Neurol Sci       Date:  2022-05-13       Impact factor: 3.830

2.  Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.

Authors:  Gholamreza Zamani; Sareh Hosseinpour; Mahmoud Reza Ashrafi; Mahmoud Mohammadi; Reza Shervin Badv; Ali Reza Tavasoli; Masood Ghahvechi Akbari; Ali Hosseini Bereshneh; Reza Azizi Malamiri; Morteza Heidari
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.903

3.  Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.

Authors:  Nasser A Elhawary; Essam H Jiffri; Samira Jambi; Ahmad H Mufti; Anas Dannoun; Hassan Kordi; Asim Khogeer; Osama H Jiffri; Abdelrahman N Elhawary; Mohammed T Tayeb
Journal:  Hum Genomics       Date:  2018-04-10       Impact factor: 4.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.